• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

患有糖皮质激素可治性醛固酮增多症的原发性醛固酮增多症患者的特征及预后

Characteristics and Outcomes in Primary Aldosteronism Patients Harboring Glucocorticoid-Remediable Aldosteronism.

作者信息

Cheng Chung-Yi, Liao Hung-Wei, Peng Kang-Yung, Chen Tso-Hsiao, Lin Yen-Hung, Chueh Jeff S, Wu Vin-Cent

机构信息

Division of Nephrology, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, No. 250 Wu-Hsing Street, Taipei 110, Taiwan.

Division of Nephrology, Department of Internal Medicine, Wan Fang Hospital, Taipei Medical University, No. 111 Section 3, Xinlong Road, Taipei 116, Taiwan.

出版信息

Biomedicines. 2021 Dec 2;9(12):1816. doi: 10.3390/biomedicines9121816.

DOI:10.3390/biomedicines9121816
PMID:34944634
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8698750/
Abstract

The clinical characteristics and surgical prognosis of glucocorticoid-remediable aldosteronism (GRA, also known as familial hyperaldosteronism type 1, FH-I) have not been widely studied. Using data from the Taiwan Primary Aldosteronism Investigation (TAIPAI) registry retrospectively, we describe the associated clinical factors for GRA and clinical predictors of surgical outcomes among identified GRA patients. We found 79 GRA-positive (51.2 ± 13.8 years; women 39 (49.4%)) and 114 GRA-negative primary aldosteronism (PA) patients matched with age, gender, and body mass index. Lower plasma aldosterone concentrations (PACs) and aldosterone-renin ratios were found among GRA-positive individuals. Multivariable logistic regression demonstrated that a PAC ≤ 40 ng/dL could predict concealed GRA individuals (OR 0.523, = 0.037). Low serum potassium (OR 0.285, = 0.008), but not the presence of GRA, was associated with hypertension-remission. Of note, PRA (OR 11.645, = 0.045) and hypokalemia (OR 0.133, = 0.048) were associated with hypertension-remission in GRA patients. Unilateral primary aldosteronism patients harboring concomitant GRA were not associated with inferior hypertension-remission after an adrenalectomy. Low serum potassium and high PRA were positively associated with hypertension-remission in GRA patients.

摘要

糖皮质激素可治性醛固酮增多症(GRA,也称为家族性醛固酮增多症1型,FH-I)的临床特征和手术预后尚未得到广泛研究。我们回顾性地利用台湾原发性醛固酮增多症调查(TAIPAI)登记处的数据,描述了GRA的相关临床因素以及已确诊GRA患者手术结果的临床预测因素。我们发现了79例GRA阳性患者(年龄51.2±13.8岁;女性39例(49.4%))和114例年龄、性别和体重指数相匹配的GRA阴性原发性醛固酮增多症(PA)患者。GRA阳性个体的血浆醛固酮浓度(PACs)和醛固酮-肾素比值较低。多变量逻辑回归显示,PAC≤40 ng/dL可预测隐匿性GRA个体(OR 0.523,P = 0.037)。低血钾(OR 0.285,P = 0.008)而非GRA的存在与高血压缓解相关。值得注意的是,PRA(OR 11.645,P = 0.045)和低钾血症(OR 0.133,P = 0.048)与GRA患者的高血压缓解相关。肾上腺切除术后,合并GRA的单侧原发性醛固酮增多症患者与较差的高血压缓解无关。低血钾和高PRA与GRA患者的高血压缓解呈正相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a005/8698750/cadf3dafa32c/biomedicines-09-01816-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a005/8698750/cadf3dafa32c/biomedicines-09-01816-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a005/8698750/cadf3dafa32c/biomedicines-09-01816-g001.jpg

相似文献

1
Characteristics and Outcomes in Primary Aldosteronism Patients Harboring Glucocorticoid-Remediable Aldosteronism.患有糖皮质激素可治性醛固酮增多症的原发性醛固酮增多症患者的特征及预后
Biomedicines. 2021 Dec 2;9(12):1816. doi: 10.3390/biomedicines9121816.
2
Detecting and treating primary aldosteronism: primary aldosteronism.原发性醛固酮增多症的检测与治疗:原发性醛固酮增多症
Exp Clin Endocrinol Diabetes. 2007 Mar;115(3):171-4. doi: 10.1055/s-2007-970409.
3
Primary hyperaldosteronism in essential hypertensives: prevalence, biochemical profile, and molecular biology.原发性高血压患者中的原发性醛固酮增多症:患病率、生化特征及分子生物学
J Clin Endocrinol Metab. 2000 May;85(5):1863-7. doi: 10.1210/jcem.85.5.6596.
4
A Chinese pedigree with glucocorticoid remediable aldosteronism.一个具有糖皮质激素可纠正性醛固酮增多症的中国家系。
Hypertens Res. 2021 Nov;44(11):1428-1433. doi: 10.1038/s41440-021-00685-3. Epub 2021 Aug 30.
5
Diagnosis of glucocorticoid-remediable aldosteronism in primary aldosteronism: aldosterone response to dexamethasone and long polymerase chain reaction for chimeric gene.原发性醛固酮增多症中糖皮质激素可治性醛固酮增多症的诊断:地塞米松刺激试验中醛固酮反应及嵌合基因的长链聚合酶链反应
J Clin Endocrinol Metab. 1998 Jul;83(7):2573-5. doi: 10.1210/jcem.83.7.4946.
6
Evaluation of the dexamethasone suppression test for the diagnosis of glucocorticoid-remediable aldosteronism.地塞米松抑制试验用于诊断糖皮质激素可治性醛固酮增多症的评估。
J Clin Endocrinol Metab. 1997 Nov;82(11):3570-3. doi: 10.1210/jcem.82.11.4381.
7
Adrenalectomy Completely Cured Hypertension in Patients With Familial Hyperaldosteronism Type I Who Had Somatic KCNJ5 Mutation.肾上腺切除术完全治愈了伴有体细胞 KCNJ5 突变的 I 型家族性醛固酮增多症患者的高血压。
J Clin Endocrinol Metab. 2019 Nov 1;104(11):5462-5466. doi: 10.1210/jc.2019-00689.
8
Impaired potassium-stimulated aldosterone production: a possible explanation for normokalemic glucocorticoid-remediable aldosteronism.钾刺激醛固酮生成受损:对正常血钾性糖皮质激素可纠正性醛固酮增多症的一种可能解释。
J Clin Endocrinol Metab. 1997 May;82(5):1507-10. doi: 10.1210/jcem.82.5.3964.
9
Plasma Aldosterone After Seated Saline Infusion Test Outperforms Captopril Test at Predicting Clinical Outcomes After Adrenalectomy for Primary Aldosteronism.坐位生理盐水输注试验后血浆醛固酮水平预测原发性醛固酮增多症患者肾上腺切除术后临床结局的效能优于卡托普利试验。
Am J Hypertens. 2019 Oct 16;32(11):1066-1074. doi: 10.1093/ajh/hpz098.
10
Prediction of successful outcome in patients with primary aldosteronism.原发性醛固酮增多症患者成功预后的预测
Curr Treat Options Oncol. 2007 Aug;8(4):314-21. doi: 10.1007/s11864-007-0039-8.

引用本文的文献

1
Genetic Testing for Primary Aldosteronism in SPAIN: Results From the SPAIN-ALDO Registry and Review of the Literature.西班牙原发性醛固酮增多症的基因检测:来自西班牙醛固酮增多症(SPAIN-ALDO)注册研究的结果及文献综述
J Clin Endocrinol Metab. 2025 Apr 22;110(5):e1573-e1579. doi: 10.1210/clinem/dgae523.
2
Differences in the clinical and hormonal presentation of patients with familial and sporadic primary aldosteronism.家族性与散发性原发性醛固酮增多症患者的临床和激素表现差异。
Front Endocrinol (Lausanne). 2024 Mar 1;15:1336306. doi: 10.3389/fendo.2024.1336306. eCollection 2024.
3
Fat mass as an important predictor of persistent hypertension in patients with primary aldosteronism after adrenalectomy.

本文引用的文献

1
Effect of Salt Substitution on Cardiovascular Events and Death.盐替代对心血管事件和死亡的影响。
N Engl J Med. 2021 Sep 16;385(12):1067-1077. doi: 10.1056/NEJMoa2105675. Epub 2021 Aug 29.
2
Re-evaluating absent clinical success after adrenalectomy in unilateral primary aldosteronism.单侧原发性醛固酮增多症肾上腺切除术后临床疗效缺失的再评估。
Surgery. 2021 Nov;170(5):1389-1396. doi: 10.1016/j.surg.2021.05.038. Epub 2021 Jun 25.
3
Renal Injuries in Primary Aldosteronism: Quantitative Histopathological Analysis of 19 Patients With Primary Adosteronism.
脂肪量是原发性醛固酮增多症患者肾上腺切除术后持续性高血压的一个重要预测指标。
Hypertens Res. 2023 Jun;46(6):1375-1384. doi: 10.1038/s41440-023-01203-3. Epub 2023 Feb 9.
原发性醛固酮增多症中的肾损伤:19 例原发性醛固酮增多症患者的定量组织病理学分析。
Hypertension. 2021 Aug;78(2):411-421. doi: 10.1161/HYPERTENSIONAHA.121.17436. Epub 2021 Jun 14.
4
Urinary sodium potassium ratio is associated with clinical success after adrenalectomy in patients with unilateral primary aldosteronism.尿钠钾比值与单侧原发性醛固酮增多症患者肾上腺切除术后的临床疗效相关。
Ther Adv Chronic Dis. 2021 Feb 12;12:2040622321990274. doi: 10.1177/2040622321990274. eCollection 2021.
5
Presence of Subclinical Hypercortisolism in Clinical Aldosterone-Producing Adenomas Predicts Lower Clinical Success.临床型醛固酮腺瘤患者亚临床皮质醇增多症的存在预示着较低的临床成功率。
Hypertension. 2020 Nov;76(5):1537-1544. doi: 10.1161/HYPERTENSIONAHA.120.15328. Epub 2020 Sep 14.
6
Arterial Stiffness Is Associated with Clinical Outcome and Cardiorenal Injury in Lateralized Primary Aldosteronism.动脉僵硬度与侧发性原发性醛固酮增多症的临床结局和心肾损伤相关。
J Clin Endocrinol Metab. 2020 Nov 1;105(11). doi: 10.1210/clinem/dgaa566.
7
Familial Aggregation and Heritability of Aldosteronism with Cardiovascular Events.醛固酮增多症的家族聚集性和心血管事件的遗传性。
J Clin Endocrinol Metab. 2020 Jun 1;105(6). doi: 10.1210/clinem/dgz257.
8
Predictors of Clinical Success After Surgery for Primary Aldosteronism in the Japanese Nationwide Cohort.日本全国队列中原发性醛固酮增多症手术后临床成功的预测因素
J Endocr Soc. 2019 Aug 22;3(11):2012-2022. doi: 10.1210/js.2019-00295. eCollection 2019 Nov 1.
9
Adrenalectomy Completely Cured Hypertension in Patients With Familial Hyperaldosteronism Type I Who Had Somatic KCNJ5 Mutation.肾上腺切除术完全治愈了伴有体细胞 KCNJ5 突变的 I 型家族性醛固酮增多症患者的高血压。
J Clin Endocrinol Metab. 2019 Nov 1;104(11):5462-5466. doi: 10.1210/jc.2019-00689.
10
Clinical Outcomes After Unilateral Adrenalectomy for Primary Aldosteronism.单侧肾上腺切除术治疗原发性醛固酮增多症的临床转归。
JAMA Surg. 2019 Apr 1;154(4):e185842. doi: 10.1001/jamasurg.2018.5842. Epub 2019 Apr 17.